A Study to Evaluate the Pharmacokinetics (How it Moves Into, Through and Out From the Body) of a New Gadolinium-based Contrast Agent (GBCA) After Injection and How Safe it is in Participants With Normal and Impaired Renal Function

Clinical trial NCT05061979 · COMPLETED

Trial details

NCT number: NCT05061979
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Contrast Enhancement in Magnetic Resonance Imaging

Start date: 2021-10-12
Primary completion: 2022-03-16
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.